| MANAGEMENT |
|
|
|
|
|
|
|
|
|
|
|
|
| • | 2
week trial of antiulcer med - d/c NSAIDs |
||||||||||
| • | If H.
pylori present - treat |
||||||||||
| • | If no
H. pylori & symptoms do not resolve |
||||||||||
| after
2 wks refer to GI for endoscopy |
|||||||||||
| • | Antiulcer
meds |
||||||||||
| – | HRA; associated with 75%-90% healing over |
||||||||||
| 4-6week
period followed by 1 yr maintenance |
|||||||||||
| – | inhibits
P-450 pathway; drug interactions |
||||||||||